Hale David F - Dec 31, 2021 Form 5 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/11/2022, 05:00 PM
Previous filing
Dec 10, 2021
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Gift $0 -125K -17.53% $0.00 588K Oct 1, 2021 By Hale BioPharma Ventures, LLC
holding ONCT Common Stock 18.3K Dec 31, 2021 By Hale Trading Company
* An asterisk sign (*) next to the price indicates that the price is likely invalid.